Wildcat Capital Management, LLC - Q2 2016 holdings

$265 Million is the total value of Wildcat Capital Management, LLC's 29 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 100.0% .

 Value Shares↓ Weighting
KITE  KITE PHARMA INC$117,904,000
+8.9%
2,358,0840.0%44.44%
+18.0%
CSGP SellCOSTAR GROUP INC$55,067,000
+15.2%
251,837
-0.9%
20.75%
+24.8%
NK  NANTKWEST INC$27,962,000
-24.3%
4,495,4950.0%10.54%
-18.0%
SRNE BuySORRENTO THERAPEUTICS INC$15,678,000
+11.1%
2,799,790
+6.7%
5.91%
+20.4%
A104PS  HILTON WORLDWIDE HLDGS INC$11,378,000
+0.0%
505,0000.0%4.29%
+8.4%
MDXG BuyMIMEDX GROUP INC$8,621,000
+3.2%
1,080,365
+13.1%
3.25%
+11.9%
NewISHARES TRcall$6,880,00061,073
+100.0%
2.59%
LPLA  LPL FINL HLDGS INC$4,612,000
-10.0%
206,6470.0%1.74%
-2.5%
CSAL  COMMUNICATIONS SALES & LEAS IN$4,364,000
+29.9%
151,0000.0%1.64%
+40.7%
NH NewNANTHEALTH INC$3,008,000240,648
+100.0%
1.13%
NewISHARES TRput$2,279,00027,164
+100.0%
0.86%
NewISHARES TRput$1,552,00013,580
+100.0%
0.58%
EDIT SellEDITAS MEDICINE INC$1,459,000
-83.0%
59,800
-75.9%
0.55%
-81.5%
SellISHARES TRcall$1,243,000
-52.6%
4,830
-51.9%
0.47%
-48.7%
NewSPDR S&P 500 ETF TRcall$864,0004,126
+100.0%
0.33%
DXJ NewWISDOMTREE TRjapn hedge eqt$776,00020,000
+100.0%
0.29%
TLT NewISHARES TR20 yr tr bd etf$669,0004,832
+100.0%
0.25%
NTLA NewINTELLIA THERAPEUTICS INC$534,00025,000
+100.0%
0.20%
NewISHARES TRput$445,0003,958
+100.0%
0.17%
ADVM NewADVERUM BIOTECHNOLOGIES INC$47,00015,000
+100.0%
0.02%
COT ExitCOTT CORP QUE$0-839
-100.0%
-0.00%
DHX ExitDHI GROUP INC$0-15,605
-100.0%
-0.04%
ExitBLACKROCK CAPITAL INVESTMENT$0-13,671
-100.0%
-0.04%
FB ExitFACEBOOK INC-Acl a$0-6,163
-100.0%
-0.24%
CMCSA ExitCOMCAST CORP-CLASS Acl a$0-11,835
-100.0%
-0.25%
AAVL ExitAVALANCHE BIOTECHNOLOGIES IN$0-235,264
-100.0%
-0.42%
GSBD ExitGOLDMAN SACHS BDC INC$0-100,000
-100.0%
-0.68%
NMFC ExitNEW MTN FIN CORP$0-179,278
-100.0%
-0.79%
ARCC ExitARES CAPITAL CORP$0-175,000
-100.0%
-0.90%
TACO ExitDEL TACO RESTAURANTS INC$0-326,478
-100.0%
-1.17%
ExitBARCLAYS BK PLCput$0-336,600
-100.0%
-2.06%
ExitSPDR S&P 500 ETF TRput$0-106,800
-100.0%
-7.64%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2016-12-02
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
COSTAR GROUP INC32Q3 202248.3%
UROGEN PHARMA LTD26Q3 202317.3%
META PLATFORMS INC26Q3 20239.9%
ALLOGENE THERAPEUTICS INC18Q3 202322.4%
GOOSEHEAD INSURANCE INC -A18Q3 202315.4%
SABINE RTY TRUST18Q3 202111.3%
LPL FINL HLDGS INC18Q1 201912.7%
PLAYA HOTELS & RESORTS NV18Q3 20213.4%
NANTKWEST INC17Q3 201922.0%
SORRENTO THERAPEUTICS INC17Q2 20197.0%

View Wildcat Capital Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Wildcat Capital Management, LLC Q2 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Skillz Inc.January 05, 202319,596,9885.6%
UroGen Pharma Ltd.February 14, 2022533,1392.4%
Skillz Inc.March 08, 202121,832,0227.5%
NantKwest, Inc.February 13, 2018808,9741.0%
Sorrento Therapeutics, Inc.February 13, 20181,738,2322.2%

View Wildcat Capital Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
32024-04-08
SC 13G2024-04-08
13F-HR2024-02-13
13F-HR2023-11-09
PX14A6G2023-11-03
13F-HR2023-08-11
13F-HR/A2023-08-10
13F-HR2023-05-12
13F-HR2023-02-07
SC 13D/A2023-01-05

View Wildcat Capital Management, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (265344000.0 != 265342000.0)
  • The reported has been restated
  • The reported has been amended

Export Wildcat Capital Management, LLC's holdings